Medical Care

Global Flow Cytometry in Oncology Market Research Report 2024

Among the clinical uses of flow cytometry cancer represents one of the most relevant. Several applications of flow cytometry can currently be applied to the study of cancer, including the detection of tumour cell DNA aneuploidy, the analysis of tumour cell proliferation and the immunophenotyping of leukemias.
The global Flow Cytometry in Oncology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Flow Cytometry in Oncology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Flow Cytometry in Oncology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Flow Cytometry in Oncology in Diagnostic Laboratories is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Flow Cytometry in Oncology include Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, bioAffinity Technologies, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation Cytek Biosciences, Cytognos, S.L., Danaher Corporation and Miltenyi Biotec B.V. and Co. KG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Flow Cytometry in Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flow Cytometry in Oncology.
Report Scope
The Flow Cytometry in Oncology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Flow Cytometry in Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flow Cytometry in Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies, Inc.
Apogee Flow Systems Ltd.
Becton, Dickinson and Company
bioAffinity Technologies, Inc.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation Cytek Biosciences
Cytognos, S.L.
Danaher Corporation
Miltenyi Biotec B.V. and Co. KG
Laboratory Corporation of America Holdings
Luminex Corporation
NeoGenomics Laboratories, Inc.
Sony Corporation
Thermo Fisher Scientific Inc
Segment by Type
Assays and Kits
Instruments
Reagents and Consumables
Software
Segment by Application
Diagnostic Laboratories
Hospitals and Healthcare Centers
Academic and Research Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flow Cytometry in Oncology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Flow Cytometry in Oncology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Assays and Kits
1.2.3 Instruments
1.2.4 Reagents and Consumables
1.2.5 Software
1.3 Market by Application
1.3.1 Global Flow Cytometry in Oncology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals and Healthcare Centers
1.3.4 Academic and Research Institutions
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Flow Cytometry in Oncology Market Perspective (2019-2030)
2.2 Flow Cytometry in Oncology Growth Trends by Region
2.2.1 Global Flow Cytometry in Oncology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Flow Cytometry in Oncology Historic Market Size by Region (2019-2024)
2.2.3 Flow Cytometry in Oncology Forecasted Market Size by Region (2025-2030)
2.3 Flow Cytometry in Oncology Market Dynamics
2.3.1 Flow Cytometry in Oncology Industry Trends
2.3.2 Flow Cytometry in Oncology Market Drivers
2.3.3 Flow Cytometry in Oncology Market Challenges
2.3.4 Flow Cytometry in Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Flow Cytometry in Oncology Players by Revenue
3.1.1 Global Top Flow Cytometry in Oncology Players by Revenue (2019-2024)
3.1.2 Global Flow Cytometry in Oncology Revenue Market Share by Players (2019-2024)
3.2 Global Flow Cytometry in Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Flow Cytometry in Oncology Revenue
3.4 Global Flow Cytometry in Oncology Market Concentration Ratio
3.4.1 Global Flow Cytometry in Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Flow Cytometry in Oncology Revenue in 2023
3.5 Flow Cytometry in Oncology Key Players Head office and Area Served
3.6 Key Players Flow Cytometry in Oncology Product Solution and Service
3.7 Date of Enter into Flow Cytometry in Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Flow Cytometry in Oncology Breakdown Data by Type
4.1 Global Flow Cytometry in Oncology Historic Market Size by Type (2019-2024)
4.2 Global Flow Cytometry in Oncology Forecasted Market Size by Type (2025-2030)
5 Flow Cytometry in Oncology Breakdown Data by Application
5.1 Global Flow Cytometry in Oncology Historic Market Size by Application (2019-2024)
5.2 Global Flow Cytometry in Oncology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Flow Cytometry in Oncology Market Size (2019-2030)
6.2 North America Flow Cytometry in Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Flow Cytometry in Oncology Market Size by Country (2019-2024)
6.4 North America Flow Cytometry in Oncology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Flow Cytometry in Oncology Market Size (2019-2030)
7.2 Europe Flow Cytometry in Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Flow Cytometry in Oncology Market Size by Country (2019-2024)
7.4 Europe Flow Cytometry in Oncology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Flow Cytometry in Oncology Market Size (2019-2030)
8.2 Asia-Pacific Flow Cytometry in Oncology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2019-2024)
8.4 Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Flow Cytometry in Oncology Market Size (2019-2030)
9.2 Latin America Flow Cytometry in Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Flow Cytometry in Oncology Market Size by Country (2019-2024)
9.4 Latin America Flow Cytometry in Oncology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Flow Cytometry in Oncology Market Size (2019-2030)
10.2 Middle East & Africa Flow Cytometry in Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2019-2024)
10.4 Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Detail
11.1.2 Agilent Technologies, Inc. Business Overview
11.1.3 Agilent Technologies, Inc. Flow Cytometry in Oncology Introduction
11.1.4 Agilent Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2019-2024)
11.1.5 Agilent Technologies, Inc. Recent Development
11.2 Apogee Flow Systems Ltd.
11.2.1 Apogee Flow Systems Ltd. Company Detail
11.2.2 Apogee Flow Systems Ltd. Business Overview
11.2.3 Apogee Flow Systems Ltd. Flow Cytometry in Oncology Introduction
11.2.4 Apogee Flow Systems Ltd. Revenue in Flow Cytometry in Oncology Business (2019-2024)
11.2.5 Apogee Flow Systems Ltd. Recent Development
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Detail
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Flow Cytometry in Oncology Introduction
11.3.4 Becton, Dickinson and Company Revenue in Flow Cytometry in Oncology Business (2019-2024)
11.3.5 Becton, Dickinson and Company Recent Development
11.4 bioAffinity Technologies, Inc.
11.4.1 bioAffinity Technologies, Inc. Company Detail
11.4.2 bioAffinity Technologies, Inc. Business Overview
11.4.3 bioAffinity Technologies, Inc. Flow Cytometry in Oncology Introduction
11.4.4 bioAffinity Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2019-2024)
11.4.5 bioAffinity Technologies, Inc. Recent Development
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Bio-Rad Laboratories, Inc. Company Detail
11.5.2 Bio-Rad Laboratories, Inc. Business Overview
11.5.3 Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Introduction
11.5.4 Bio-Rad Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2019-2024)
11.5.5 Bio-Rad Laboratories, Inc. Recent Development
11.6 Bio-Techne Corporation Cytek Biosciences
11.6.1 Bio-Techne Corporation Cytek Biosciences Company Detail
11.6.2 Bio-Techne Corporation Cytek Biosciences Business Overview
11.6.3 Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Introduction
11.6.4 Bio-Techne Corporation Cytek Biosciences Revenue in Flow Cytometry in Oncology Business (2019-2024)
11.6.5 Bio-Techne Corporation Cytek Biosciences Recent Development
11.7 Cytognos, S.L.
11.7.1 Cytognos, S.L. Company Detail
11.7.2 Cytognos, S.L. Business Overview
11.7.3 Cytognos, S.L. Flow Cytometry in Oncology Introduction
11.7.4 Cytognos, S.L. Revenue in Flow Cytometry in Oncology Business (2019-2024)
11.7.5 Cytognos, S.L. Recent Development
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Detail
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation Flow Cytometry in Oncology Introduction
11.8.4 Danaher Corporation Revenue in Flow Cytometry in Oncology Business (2019-2024)
11.8.5 Danaher Corporation Recent Development
11.9 Miltenyi Biotec B.V. and Co. KG
11.9.1 Miltenyi Biotec B.V. and Co. KG Company Detail
11.9.2 Miltenyi Biotec B.V. and Co. KG Business Overview
11.9.3 Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Introduction
11.9.4 Miltenyi Biotec B.V. and Co. KG Revenue in Flow Cytometry in Oncology Business (2019-2024)
11.9.5 Miltenyi Biotec B.V. and Co. KG Recent Development
11.10 Laboratory Corporation of America Holdings
11.10.1 Laboratory Corporation of America Holdings Company Detail
11.10.2 Laboratory Corporation of America Holdings Business Overview
11.10.3 Laboratory Corporation of America Holdings Flow Cytometry in Oncology Introduction
11.10.4 Laboratory Corporation of America Holdings Revenue in Flow Cytometry in Oncology Business (2019-2024)
11.10.5 Laboratory Corporation of America Holdings Recent Development
11.11 Luminex Corporation
11.11.1 Luminex Corporation Company Detail
11.11.2 Luminex Corporation Business Overview
11.11.3 Luminex Corporation Flow Cytometry in Oncology Introduction
11.11.4 Luminex Corporation Revenue in Flow Cytometry in Oncology Business (2019-2024)
11.11.5 Luminex Corporation Recent Development
11.12 NeoGenomics Laboratories, Inc.
11.12.1 NeoGenomics Laboratories, Inc. Company Detail
11.12.2 NeoGenomics Laboratories, Inc. Business Overview
11.12.3 NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Introduction
11.12.4 NeoGenomics Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2019-2024)
11.12.5 NeoGenomics Laboratories, Inc. Recent Development
11.13 Sony Corporation
11.13.1 Sony Corporation Company Detail
11.13.2 Sony Corporation Business Overview
11.13.3 Sony Corporation Flow Cytometry in Oncology Introduction
11.13.4 Sony Corporation Revenue in Flow Cytometry in Oncology Business (2019-2024)
11.13.5 Sony Corporation Recent Development
11.14 Thermo Fisher Scientific Inc
11.14.1 Thermo Fisher Scientific Inc Company Detail
11.14.2 Thermo Fisher Scientific Inc Business Overview
11.14.3 Thermo Fisher Scientific Inc Flow Cytometry in Oncology Introduction
11.14.4 Thermo Fisher Scientific Inc Revenue in Flow Cytometry in Oncology Business (2019-2024)
11.14.5 Thermo Fisher Scientific Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Flow Cytometry in Oncology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Assays and Kits
Table 3. Key Players of Instruments
Table 4. Key Players of Reagents and Consumables
Table 5. Key Players of Software
Table 6. Global Flow Cytometry in Oncology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Flow Cytometry in Oncology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Flow Cytometry in Oncology Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Flow Cytometry in Oncology Market Share by Region (2019-2024)
Table 10. Global Flow Cytometry in Oncology Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Flow Cytometry in Oncology Market Share by Region (2025-2030)
Table 12. Flow Cytometry in Oncology Market Trends
Table 13. Flow Cytometry in Oncology Market Drivers
Table 14. Flow Cytometry in Oncology Market Challenges
Table 15. Flow Cytometry in Oncology Market Restraints
Table 16. Global Flow Cytometry in Oncology Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Flow Cytometry in Oncology Market Share by Players (2019-2024)
Table 18. Global Top Flow Cytometry in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flow Cytometry in Oncology as of 2023)
Table 19. Ranking of Global Top Flow Cytometry in Oncology Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Flow Cytometry in Oncology Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Flow Cytometry in Oncology Product Solution and Service
Table 23. Date of Enter into Flow Cytometry in Oncology Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Flow Cytometry in Oncology Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Flow Cytometry in Oncology Revenue Market Share by Type (2019-2024)
Table 27. Global Flow Cytometry in Oncology Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Flow Cytometry in Oncology Revenue Market Share by Type (2025-2030)
Table 29. Global Flow Cytometry in Oncology Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Flow Cytometry in Oncology Revenue Market Share by Application (2019-2024)
Table 31. Global Flow Cytometry in Oncology Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Flow Cytometry in Oncology Revenue Market Share by Application (2025-2030)
Table 33. North America Flow Cytometry in Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Flow Cytometry in Oncology Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Flow Cytometry in Oncology Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Flow Cytometry in Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Flow Cytometry in Oncology Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Flow Cytometry in Oncology Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Flow Cytometry in Oncology Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Flow Cytometry in Oncology Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Flow Cytometry in Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Flow Cytometry in Oncology Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Flow Cytometry in Oncology Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Flow Cytometry in Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Flow Cytometry in Oncology Market Size by Country (2025-2030) & (US$ Million)
Table 48. Agilent Technologies, Inc. Company Detail
Table 49. Agilent Technologies, Inc. Business Overview
Table 50. Agilent Technologies, Inc. Flow Cytometry in Oncology Product
Table 51. Agilent Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2019-2024) & (US$ Million)
Table 52. Agilent Technologies, Inc. Recent Development
Table 53. Apogee Flow Systems Ltd. Company Detail
Table 54. Apogee Flow Systems Ltd. Business Overview
Table 55. Apogee Flow Systems Ltd. Flow Cytometry in Oncology Product
Table 56. Apogee Flow Systems Ltd. Revenue in Flow Cytometry in Oncology Business (2019-2024) & (US$ Million)
Table 57. Apogee Flow Systems Ltd. Recent Development
Table 58. Becton, Dickinson and Company Company Detail
Table 59. Becton, Dickinson and Company Business Overview
Table 60. Becton, Dickinson and Company Flow Cytometry in Oncology Product
Table 61. Becton, Dickinson and Company Revenue in Flow Cytometry in Oncology Business (2019-2024) & (US$ Million)
Table 62. Becton, Dickinson and Company Recent Development
Table 63. bioAffinity Technologies, Inc. Company Detail
Table 64. bioAffinity Technologies, Inc. Business Overview
Table 65. bioAffinity Technologies, Inc. Flow Cytometry in Oncology Product
Table 66. bioAffinity Technologies, Inc. Revenue in Flow Cytometry in Oncology Business (2019-2024) & (US$ Million)
Table 67. bioAffinity Technologies, Inc. Recent Development
Table 68. Bio-Rad Laboratories, Inc. Company Detail
Table 69. Bio-Rad Laboratories, Inc. Business Overview
Table 70. Bio-Rad Laboratories, Inc. Flow Cytometry in Oncology Product
Table 71. Bio-Rad Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2019-2024) & (US$ Million)
Table 72. Bio-Rad Laboratories, Inc. Recent Development
Table 73. Bio-Techne Corporation Cytek Biosciences Company Detail
Table 74. Bio-Techne Corporation Cytek Biosciences Business Overview
Table 75. Bio-Techne Corporation Cytek Biosciences Flow Cytometry in Oncology Product
Table 76. Bio-Techne Corporation Cytek Biosciences Revenue in Flow Cytometry in Oncology Business (2019-2024) & (US$ Million)
Table 77. Bio-Techne Corporation Cytek Biosciences Recent Development
Table 78. Cytognos, S.L. Company Detail
Table 79. Cytognos, S.L. Business Overview
Table 80. Cytognos, S.L. Flow Cytometry in Oncology Product
Table 81. Cytognos, S.L. Revenue in Flow Cytometry in Oncology Business (2019-2024) & (US$ Million)
Table 82. Cytognos, S.L. Recent Development
Table 83. Danaher Corporation Company Detail
Table 84. Danaher Corporation Business Overview
Table 85. Danaher Corporation Flow Cytometry in Oncology Product
Table 86. Danaher Corporation Revenue in Flow Cytometry in Oncology Business (2019-2024) & (US$ Million)
Table 87. Danaher Corporation Recent Development
Table 88. Miltenyi Biotec B.V. and Co. KG Company Detail
Table 89. Miltenyi Biotec B.V. and Co. KG Business Overview
Table 90. Miltenyi Biotec B.V. and Co. KG Flow Cytometry in Oncology Product
Table 91. Miltenyi Biotec B.V. and Co. KG Revenue in Flow Cytometry in Oncology Business (2019-2024) & (US$ Million)
Table 92. Miltenyi Biotec B.V. and Co. KG Recent Development
Table 93. Laboratory Corporation of America Holdings Company Detail
Table 94. Laboratory Corporation of America Holdings Business Overview
Table 95. Laboratory Corporation of America Holdings Flow Cytometry in Oncology Product
Table 96. Laboratory Corporation of America Holdings Revenue in Flow Cytometry in Oncology Business (2019-2024) & (US$ Million)
Table 97. Laboratory Corporation of America Holdings Recent Development
Table 98. Luminex Corporation Company Detail
Table 99. Luminex Corporation Business Overview
Table 100. Luminex Corporation Flow Cytometry in Oncology Product
Table 101. Luminex Corporation Revenue in Flow Cytometry in Oncology Business (2019-2024) & (US$ Million)
Table 102. Luminex Corporation Recent Development
Table 103. NeoGenomics Laboratories, Inc. Company Detail
Table 104. NeoGenomics Laboratories, Inc. Business Overview
Table 105. NeoGenomics Laboratories, Inc. Flow Cytometry in Oncology Product
Table 106. NeoGenomics Laboratories, Inc. Revenue in Flow Cytometry in Oncology Business (2019-2024) & (US$ Million)
Table 107. NeoGenomics Laboratories, Inc. Recent Development
Table 108. Sony Corporation Company Detail
Table 109. Sony Corporation Business Overview
Table 110. Sony Corporation Flow Cytometry in Oncology Product
Table 111. Sony Corporation Revenue in Flow Cytometry in Oncology Business (2019-2024) & (US$ Million)
Table 112. Sony Corporation Recent Development
Table 113. Thermo Fisher Scientific Inc Company Detail
Table 114. Thermo Fisher Scientific Inc Business Overview
Table 115. Thermo Fisher Scientific Inc Flow Cytometry in Oncology Product
Table 116. Thermo Fisher Scientific Inc Revenue in Flow Cytometry in Oncology Business (2019-2024) & (US$ Million)
Table 117. Thermo Fisher Scientific Inc Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Flow Cytometry in Oncology Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Flow Cytometry in Oncology Market Share by Type: 2023 VS 2030
Figure 3. Assays and Kits Features
Figure 4. Instruments Features
Figure 5. Reagents and Consumables Features
Figure 6. Software Features
Figure 7. Global Flow Cytometry in Oncology Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Flow Cytometry in Oncology Market Share by Application: 2023 VS 2030
Figure 9. Diagnostic Laboratories Case Studies
Figure 10. Hospitals and Healthcare Centers Case Studies
Figure 11. Academic and Research Institutions Case Studies
Figure 12. Others Case Studies
Figure 13. Flow Cytometry in Oncology Report Years Considered
Figure 14. Global Flow Cytometry in Oncology Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Flow Cytometry in Oncology Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Flow Cytometry in Oncology Market Share by Region: 2023 VS 2030
Figure 17. Global Flow Cytometry in Oncology Market Share by Players in 2023
Figure 18. Global Top Flow Cytometry in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flow Cytometry in Oncology as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Flow Cytometry in Oncology Revenue in 2023
Figure 20. North America Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Flow Cytometry in Oncology Market Share by Country (2019-2030)
Figure 22. United States Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Flow Cytometry in Oncology Market Share by Country (2019-2030)
Figure 26. Germany Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Flow Cytometry in Oncology Market Share by Region (2019-2030)
Figure 34. China Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Flow Cytometry in Oncology Market Share by Country (2019-2030)
Figure 42. Mexico Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Flow Cytometry in Oncology Market Share by Country (2019-2030)
Figure 46. Turkey Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Flow Cytometry in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Agilent Technologies, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2019-2024)
Figure 49. Apogee Flow Systems Ltd. Revenue Growth Rate in Flow Cytometry in Oncology Business (2019-2024)
Figure 50. Becton, Dickinson and Company Revenue Growth Rate in Flow Cytometry in Oncology Business (2019-2024)
Figure 51. bioAffinity Technologies, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2019-2024)
Figure 52. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2019-2024)
Figure 53. Bio-Techne Corporation Cytek Biosciences Revenue Growth Rate in Flow Cytometry in Oncology Business (2019-2024)
Figure 54. Cytognos, S.L. Revenue Growth Rate in Flow Cytometry in Oncology Business (2019-2024)
Figure 55. Danaher Corporation Revenue Growth Rate in Flow Cytometry in Oncology Business (2019-2024)
Figure 56. Miltenyi Biotec B.V. and Co. KG Revenue Growth Rate in Flow Cytometry in Oncology Business (2019-2024)
Figure 57. Laboratory Corporation of America Holdings Revenue Growth Rate in Flow Cytometry in Oncology Business (2019-2024)
Figure 58. Luminex Corporation Revenue Growth Rate in Flow Cytometry in Oncology Business (2019-2024)
Figure 59. NeoGenomics Laboratories, Inc. Revenue Growth Rate in Flow Cytometry in Oncology Business (2019-2024)
Figure 60. Sony Corporation Revenue Growth Rate in Flow Cytometry in Oncology Business (2019-2024)
Figure 61. Thermo Fisher Scientific Inc Revenue Growth Rate in Flow Cytometry in Oncology Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies